Global Pediatric Vaccine Market Overview: Trends Shaping Growth to 2029
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Pediatric Vaccine Industry Expected To Reach By 2029, Starting From 2025 Levels?
The pediatric vaccine market has experienced robust expansion in recent years. Forecasts indicate it will grow from $44.2 billion in 2024 to $46.95 billion by 2025, achieving a compound annual growth rate (CAGR) of 6.2%. This growth observed in the preceding period is attributable to an increased prevalence of chronic diseases, the establishment of immunization policies aimed at eradicating endemic diseases, and enhanced funding for vaccine development.
The pediatric vaccine market is anticipated to experience robust expansion over the coming years. Its value is projected to reach $62.48 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.4%. This forecasted growth is largely driven by factors such as the rising incidence of invasive cervical cancer, a robust pipeline of late-stage developments and new drug approvals, and the growing occurrence of infectious diseases. Key trends during this period are expected to involve creating combination vaccines to satisfy market needs, increasing investment in R&D for developing potent vaccines, concentrating on live attenuated vaccine development, employing novel immune engineering and advanced delivery systems, and integrating artificial intelligence (AI) into vaccine creation to streamline procedures and facilitate manufacturing.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp
Which Factors And Drivers Are Influencing The Pediatric Vaccine Market In 2025?
An increasing occurrence of chronic illnesses, including tuberculosis, diphtheria, and pneumonia, among individuals aged 15 years and younger, is expected to fuel the expansion of the pediatric vaccines market. Furthermore, children and adolescents living with chronic conditions face a growing danger of experiencing severe disease manifestations and complications from infectious diseases. For instance, in March 2022, data from the Australian Bureau of Statistics, an Australia-based self-governing statutory body entrusted with gathering and evaluating data and providing factual recommendations, revealed that approximately half of the total population (46.6%, or 11.6 million individuals) was affected by at least one chronic ailment. This elevated incidence of chronic diseases in children consequently boosts the need for immunization against these conditions, thereby propelling the growth of the pediatric vaccines market.
What Are The Leading Segments Analyzed In The Pediatric Vaccine Market?
The pediatric vaccine market covered in this report is segmented –
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies
3) By Application: Infectious Disease, Allergy, Cancer
Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Polyvalent Vaccines
What Long-Term Trends Will Shape The Future Growth Of The Pediatric Vaccine Industry?
A consistent rise in the need for new vaccines is observed, aimed at enhancing immunity against challenging infectious diseases like tuberculosis and HIV/AIDS, alongside chronic non-communicable conditions such as cancer and neurodegenerative illnesses. Innovative strategies in vaccine creation encompass structural immunogenic design, gene-based vaccine technologies, and potent adjuvant recombinant antigen formulations. To address this escalating demand for new vaccines, pediatric vaccine producers and developers are continuously seeking advancements in vaccine design and manufacturing technologies. For instance, in April 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company, announced the U.S. FDA approval of REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine for children and infants.
Which Major Firms Are Strengthening Their Position In The Pediatric Vaccine Industry?
Major companies operating in the pediatric vaccine market include Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., AstraZeneca, GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, CSL Limited, BIO-MED, Sun Pharmaceutical Industries Ltd, Sinopharm, Walvax biotechnology, Fosun Pharma, BioNTech, MCM Vaccine Company, Seqirus, Roche, Johnson & Johnson, Novartis, Connaught LaboratoriesInc., Wyeth-Ayerst, Grifols, Ataulfo de Paiva Foundation, Bio-Manguinhos–Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report
Which Region Shows The Highest Potential For Future Expansion In The Pediatric Vaccine Market?
North America was the largest region in the pediatric vaccine market in 2024. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Pediatric Vaccine Market Report:
https://www.thebusinessresearchcompany.com/customise?id=2824&type=smp
Browse Through More Reports Similar to the Global Pediatric Vaccine Market 2025, By The Business Research Company
Hearing Aid Devices And Equipment Global Market Report 2025
Hearing Implants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hearing-implants-global-market-report
Anesthesia Disposables Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/anesthesia-disposables-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
